|
metatricycloene |
8 |
0.54 |
0.5 |
0.71 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
NC(=O)/C=C/C=C/C1C=CC2C=CC3OC(/C=C/C=C/C=C/C(=O)O)C1C23 |
view |
metatricycloene |
|
|
heronamide C |
0 |
0.59 |
0.55 |
0.77 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCC/C=C\C=C/C[C@H]1C/C=C\C=C(C)/C=C\C=C/[C@H](O)[C@H](O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
heronamide C |
|
|
isorenieratene |
1 |
0.59 |
0.55 |
0.76 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC(/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)=C\C=C\C=C(C)\C=C\C=C(C)\C=C\c1c(C)ccc(C)c1C |
view |
isorenieratene |
|
|
Elansolid A1 |
2 |
0.58 |
0.53 |
0.77 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COC(c1ccc(O)cc1)C1C(/C=C\C=C\C=C/C(O)C(C)C(O)C/C=C(C)/C=C/C(=O)O)C(C)=CC2C1C(C)(C)C[C@]2(C)O |
view |
Elansolid A1 |
|
|
BE-14106 |
3 |
0.58 |
0.55 |
0.75 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCC/C=C/CC1C/C=C\C=C(C)/C=C\C=C/C(O)C(O)/C=C(C)\C=C/C=C\C(=O)N1 |
view |
BE-14106 |
|
|
xanthomonadin |
4 |
0.56 |
0.52 |
0.73 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COc1cc(/C(Br)=C/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C(=O)OCC(C)C)ccc1Br |
view |
xanthomonadin |
|
|
beta-carotein |
5 |
0.55 |
0.47 |
0.75 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)C(C)(C)CCC1 |
view |
beta-carotein |
|
|
Spirangien A1 |
6 |
0.54 |
0.44 |
0.74 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C=C(\C)C[C@H](C)[C@H](O)[C@@H](C)[C@H]1O[C@@]2(C[C@@H](OC)[C@H]1C)O[C@H]([C@@H](C)[C@@H](O)[C@@H](C)/C=C\C=C\C=C/C=C/C=C\[C@H](CC(=O)O)OC)[C@@H](C)C[C@@H]2O |
view |
Spirangien A1 |
|
|
astaxanthin |
7 |
0.54 |
0.48 |
0.73 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C(=O)C(O)CC2(C)C)C(C)(C)CC(O)C1=O |
view |
astaxanthin |
|
|
hitachimycin |
9 |
0.54 |
0.51 |
0.69 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@H]1C[C@@H]2/C=C(C)\C=C/C=C\C(=O)N[C@@H](c3ccccc3)C/C=C\CC[C@H](O)CC(=O)C2=C1O |
view |
hitachimycin |
|
|
APE Ec |
10 |
0.53 |
0.48 |
0.71 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COC(=O)/C=C/C=C/C=C/C=C/C=C/C=C/c1ccc(O)c(C)c1 |
view |
APE Ec |
|
|
phenalamide |
11 |
0.53 |
0.66 |
0.56 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C(\C)C(=O)NC(C)CO)=C\C(C)C(O)/C(C)=C/C(C)CCc1ccccc1 |
view |
phenalamide |
|
|
heronamide D |
12 |
0.52 |
0.42 |
0.72 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C=C/C=C/CC1C[C@H](O)C2C3/C(C)=C\C4C=C[C@@H](O)[C@@H](O)C4/C(C)=C\C=C/C3C(=O)N12 |
view |
heronamide D |
|
|
APE Vf |
13 |
0.52 |
0.47 |
0.69 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COC(=O)/C=C/C=C/C=C/C=C/C=C/C=C/c1cc(C)c(O)c(C)c1 |
view |
APE Vf |
|
|
Soraphen |
14 |
0.5 |
0.44 |
0.66 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
*[C@@H]1/C=C\C(C)[C@@H]2O[C@@](O)([C@H](C)C(=O)O[C@H](c3ccccc3)CCCC[C@@H]1*)[C@H](*)[C@@H](O)[C@@H]2C |
view |
Soraphen |
|
|
myxalamid |
15 |
0.5 |
0.54 |
0.6 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC(/C=C/C=C\C=C\C=C(/C)C(=O)N[C@@H](C)CO)=C\[C@@H](C)[C@@H](O)/C(C)=C/C(C)C |
view |
myxalamid |
|
|
naphthomycin |
16 |
0.49 |
0.42 |
0.66 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C1=C/C[C@H](O)/C=C\[C@H](C)[C@H](O)[C@@H](C)/C=C(/C)C(=O)c2c(O)c(C)cc3c2C(=O)C(Cl)=C(NC(=O)/C(C)=C\C=C/C=C\[C@H](C)[C@@H](O)CC1=O)C3=O |
view |
naphthomycin |
|
|
heronamide B |
17 |
0.49 |
0.45 |
0.64 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCC/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@@H]3C=C[C@H](O)[C@H](O)[C@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide B |
|
|
flexirubin |
18 |
0.49 |
0.46 |
0.63 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCCCCCCCCCCCc1c(O)cc(C)cc1OC(=O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C=C/c1ccc(O)c(C)c1 |
view |
flexirubin |
|
|
bongkrekic acid |
19 |
0.48 |
0.44 |
0.64 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COC(C/C=C\C=C\CC/C=C/CC(C)/C=C/C(=C\C(=O)O)CC(=O)O)/C(C)=C\C=C(/C)C(=O)O |
view |
bongkrekic acid |
|
|
macrobrevin |
20 |
0.48 |
0.42 |
0.64 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCC(C)C(O)/C=C/C(C)=C/C=C/C(C)CC(C)C1CC(O)C(C)/C=C\C=C/C(C)C/C=C(/C)C(O)/C=C\CC(O)C(C)/C=C\C(=O)O1 |
view |
macrobrevin |
|
|
isobongkrekic acid |
21 |
0.48 |
0.46 |
0.61 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@H](C/C=C\C=C\CC/C=C/C[C@H](C)/C=C/C(=C/C(=O)O)CC(=O)O)/C(C)=C\C=C(C)C |
view |
isobongkrekic acid |
|
|
heronamide E |
22 |
0.48 |
0.46 |
0.61 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C=C/C=C/C[C@@H]1C[C@@H]2/C=C\C(C)=C/[C@H]3C=C[C@@H](O)[C@@H](O)[C@@H]3/C(C)=C\C=C/[C@H]2C(=O)N1 |
view |
heronamide E |
|
|
thailandamide B |
23 |
0.48 |
0.55 |
0.55 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@H](/C(C)=C/C=C/C=C(C)/C=C/C[C@H](O)CC(=O)/C=C\C=C(C)\C=C\[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1)[C@@H](C)C(=O)O |
view |
thailandamide B |
|
|
thailandamide A |
24 |
0.48 |
0.55 |
0.55 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@H](/C(C)=C/C=C/C=C(C)/C=C/C[C@H](O)CC(=O)/C=C/C=C(C)/C=C/[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1)[C@@H](C)C(=O)O |
view |
thailandamide A |
|
|
azaspirene |
25 |
0.47 |
0.46 |
0.6 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC/C=C/C=C/C1=C(C)C(=O)C2(O1)C(=O)N[C@@](O)(Cc1ccccc1)[C@@H]2O |
view |
azaspirene |
|
|
Etnangien |
26 |
0.46 |
0.43 |
0.6 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COC1C(C)C(O)CC(=O)OC(C(C)C(O)/C=C(C)/C=C/C=C/C=C/C=C/C=C/CC(O)/C=C(\C)CCC(=O)O)CC(O)CCCC(O)C/C=C\C=C/CC(C)C(O)C1C |
view |
Etnangien |
|
|
alpha-lipomycin |
27 |
0.46 |
0.47 |
0.47 |
0.4 |
Glyco:1/3 * NO2:0/1 |
MIBiG |
Source |
CC(/C=C/C=C/C=C/C=C/C(=O)C1=C(O)C(CCC(=O)O)N(C)C1=O)=C\C(C)C(O[C@H]1C[C@H](O)[C@H](O)[C@@H](C)O1)C(C)C |
view |
alpha-lipomycin |
|
|
enacyloxin |
28 |
0.45 |
0.43 |
0.58 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC/C=C/[C@@H](OC(N)=O)[C@@H](Cl)[C@H](O)CC(=O)C(O)C(O)[C@H](C)/C(Cl)=C/C=C/C=C(C)/C=C/C=C/C(=O)O[C@@H]1C[C@@H](C(=O)O)CC[C@@H]1O |
view |
enacyloxin |
|
|
Dawenol |
29 |
0.45 |
0.53 |
0.5 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C=C\C(C)=C\C=C\C(C)=C\C=C\C(C)=C\C(C)=C\C(C)C(O)C(C)C(C)OC(C)=O |
view |
Dawenol |
|
|
cytochalasin E |
30 |
0.44 |
0.44 |
0.54 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C[C@H]1C/C=C\[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]23OC(=O)O/C=C\[C@@](C)(O)C1=O |
view |
cytochalasin E |
|
|
zeaxanthin |
31 |
0.44 |
0.48 |
0.53 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C)C(C)(C)C[C@H](O)C1 |
view |
zeaxanthin |
|
|
cytochalasin K |
32 |
0.44 |
0.47 |
0.53 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC1=C(C)[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@]23OC(=O)O/C=C\[C@@](C)(O)C(=O)[C@@H](C)C/C=C\[C@H]3[C@@H]1O |
view |
cytochalasin K |
|
|
thailandamide lactone |
33 |
0.43 |
0.54 |
0.46 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@H]1[C@@H](C)C(=O)O[C@@]1(C)/C=C/C=C/C(C)=C/C=C/C(O)=C/C(=O)/C=C/C=C(C)/C=C/[C@@H](C)NC(=O)[C@H](C)C/C=C/C[C@@H](O)Cc1ccc(O)cc1 |
view |
thailandamide lactone |
|
|
crocacin |
34 |
0.42 |
0.47 |
0.48 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COC(=O)CNC(=O)/C=C\C/C=C\NC(=O)/C=C(C)/C=C/[C@H](C)[C@H](OC)[C@H](C)[C@H](/C=C/c1ccccc1)OC |
view |
crocacin |
|
|
bacillaene |
35 |
0.42 |
0.53 |
0.44 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C(=C/C=C/C=C/C(C)C(=O)O)NC(=O)CC(O)/C(C)=C\C=C/C=C(C)/C=C/C=C\CCCNC(=O)C(O)CC(C)C |
view |
bacillaene |
|
|
citreoviridin |
36 |
0.39 |
0.42 |
0.46 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
COc1cc(=O)oc(/C=C/C=C/C=C/C(C)=C/[C@]2(C)O[C@H](C)[C@](C)(O)[C@H]2O)c1C |
view |
citreoviridin |
|
|
fumagillin |
37 |
0.39 |
0.49 |
0.41 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@H]1[C@H]([C@@]2(C)O[C@@H]2CC=C(C)C)[C@]2(CC[C@H]1OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)CO2 |
view |
fumagillin |
|
|
Chivosazol |
38 |
0.39 |
0.43 |
0.35 |
0.4 |
Glyco:1/3 * NO2:0/1 |
MIBiG |
Source |
COC1CC(O)/C=C\C=C/C=C\C(C)C(C(C)C(O)CC(C)O)OC(=O)/C=C\C=C/C=C\C(C)=C/C(C)C(OC2O[C@H](C)[C@@H](O)[C@H](OC)[C@H]2OC)/C=C\C=C/c2coc(n2)C1C |
view |
Chivosazol |
|
|
colabomycin E |
39 |
0.36 |
0.42 |
0.4 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C=C/C=C\C=C\C=C\C=C\C(=O)NC1=C[C@@](O)(/C=C/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)C2OC2C1=O |
view |
colabomycin E |
|
|
AK-toxin |
40 |
0.36 |
0.53 |
0.33 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC(=O)NC(C(=O)OC(/C=C/C=C\C=C\C(=O)O)C1(C)CO1)C(C)c1ccccc1 |
view |
AK-toxin |
|
|
Hapalosin |
41 |
0.34 |
0.43 |
0.36 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCCCCCC[C@H]1OC(=O)C[C@@H](O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](C(C)C)OC(=O)[C@H]1C |
view |
Hapalosin |
|
|
asukamycin |
42 |
0.33 |
0.41 |
0.35 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
O=C(/C=C/C=C/C=C/C1CCCCC1)NC1=C[C@@](O)(/C=C/C=C/C=C/C(=O)NC2=C(O)CCC2=O)[C@@H]2O[C@@H]2C1=O |
view |
asukamycin |
|
|
oxazolomycin |
43 |
0.33 |
0.42 |
0.34 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CO[C@@H](C[C@@H](C)C(O)/C=C/C=C/CNC(=O)C(C)(C)C(O)/C(C)=C\C=C/C=C/Cc1cnco1)[C@]1(O)[C@@H](C)C(=O)N(C)C12COC2=O |
view |
oxazolomycin |
|
|
AF-toxin |
44 |
0.33 |
0.45 |
0.33 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CCC(C)C(OC(=O)C(O)C(C)(C)O)C(=O)OC(/C=C/C=C/C=C/C(=O)O)C1(C)CO1 |
view |
AF-toxin |
|
|
andrimid |
45 |
0.32 |
0.48 |
0.27 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C/C=C/C=C/C=C/C(=O)N[C@@H](CC(=O)N[C@H](C(=O)[C@@H]1C(=O)NC(=O)[C@H]1C)C(C)C)c1ccccc1 |
view |
andrimid |
|
|
haliamide |
46 |
0.31 |
0.45 |
0.28 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
C=CC(C)C/C(C)=C/C=C/C(C)NC(=O)c1ccccc1 |
view |
haliamide |
|
|
Rhabdopeptide 1 |
47 |
0.28 |
0.43 |
0.23 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CN[C@@H](CC(C)C)C(=O)N(C)[C@H](C(=O)N[C@H](C(=O)N(C)[C@H](C(=O)NCCc1ccccc1)C(C)C)C(C)C)C(C)C |
view |
Rhabdopeptide 1 |
|
|
Rhabdopeptide 2 |
48 |
0.28 |
0.43 |
0.23 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CN[C@@H](C(=O)N(C)[C@H](CC(C)C)C(=O)N(C)[C@@H](C(=O)N(C)[C@@H](C(=O)NCCc1ccccc1)C(C)C)C(C)C)C(C)C |
view |
Rhabdopeptide 2 |
|
|
vulnibactin |
49 |
0.25 |
0.42 |
0.18 |
0.0 |
Glyco:0/3 * NO2:0/1 |
MIBiG |
Source |
CC1O/C(=C2/C=CC=CC2=O)NC1C(=O)NCCCN(CCCNC(=O)c1cccc(O)c1O)C(=O)[C@H]1N/C(=C2\C=CC=CC2=O)O[C@@H]1C |
view |
vulnibactin |
|